Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Boston Scientific Neuromodulation · Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

98 daysmedian FDA review time
376 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K233801Nalu Neurostimulation System for Spinal Cord Stimulation; NaBoston Scientific Neuromodulation2024-08-232680
K232415Nalu Neurostimulation System for Peripheral Nerve StimulatioBoston Scientific Neuromodulation2024-08-213760
K221376Nalu Neurostimulation SystemBoston Scientific Neuromodulation2022-06-10290
K203547Nalu Neurostimulation SystemBoston Scientific Neuromodulation2021-03-251110
K202274Nalu Neurostimulation Kit (lnte:gmted 40 em: Single 8/Dual 8Boston Scientific Neuromodulation2020-11-09900
K201618Nalu Neurostimulation SCS systemBoston Scientific Neuromodulation2020-07-15300
K190960Nalu Lead Blank (50cm)Boston Scientific Neuromodulation2019-07-11900
K183579Nalu Neurostimulation Kit (Integrated, 40 cm: Single 8/Dual Boston Scientific Neuromodulation2019-03-29981
K183047Nalu Neurostimulation SystemBoston Scientific Neuromodulation2019-03-221401

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda